# REVLIMID
> **NDA021880** · New Drug Application · Sponsor: BRISTOL MYERS SQUIBB · Approved 2005-12-27
## Drug
- **FDA Application Number:** NDA021880
- **Application type:** New Drug Application
- **Brand name:** REVLIMID
- **Generic name:** LENALIDOMIDE
- **Active ingredients:** LENALIDOMIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BRISTOL MYERS SQUIBB
- **Manufacturer:** Celgene Corporation
- **First approval:** 2005-12-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021880)
---
*MORVS · CC0 1.0*